Skip to main content
Caplight Logo









ApoGlyx

ApoGlyx

Private
LundHealthcare & Life Scienceshttps://apoglyx.com/

Last Round

VC Round

Oct 25, 2021

Total Funding Raised

$605,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ApoGlyx is a biotechnology company developing first-in-class therapies based on aquaporin inhibitors for inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

Aquaporin-9 inhibitorAQP9 inhibitorsmall molecule inhibitorfirst-in-class drugacute pancreatitispreclinical biotechnovel drug targetdrug discoveryinflammatory diseasesbiopharma R&Dsepsismetabolic diseasespharma licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ApoGlyx Comparables

Compare ApoGlyx with similar companies based on industry and business-model similarity.

ApoGlyx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arrivo BioVentures
80%
Lamassu BioTech
78%
CalciMedica Inc.
73%

ApoGlyx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 25, 2021
SeedJun 2, 2016

ApoGlyx Investors

Notable investors and investment history

ApoGlyx investors
InvestorRounds
LU InnovationSeed
Almi Invest ABVC Round
SmiLe Venture HubSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 34% MoM, reaching 1.3K.

  • May 18, 2026

    Monthly visitors grew 48% MoM, reaching 1K.

ApoGlyx Filings

Explore SEC and related filing metadata, where available.

ApoGlyx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ApoGlyx's valuation, stock price, and market status.

Is ApoGlyx a public or private company?

ApoGlyx is a private company.

What is the current stock price of ApoGlyx?

ApoGlyx is a private company with no public stock price. No recent secondary market data is available.

How much is ApoGlyx worth (valuation)?

Valuation information for ApoGlyx is not publicly available.

Can I buy ApoGlyx stock?

ApoGlyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ApoGlyx's last funding round?

ApoGlyx's most recent funding round was VC Round on October 25, 2021.

Who are the main investors in ApoGlyx?

Key investors in ApoGlyx include Almi Invest AB.

Will ApoGlyx IPO soon?

No public IPO plans have been announced for ApoGlyx.

How can I track ApoGlyx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ApoGlyx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLund
Employee Range3
Year Founded2015
Last FundingOct 25, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?